Clinical Trials
9 trialsNCT00635245 2015-03-11
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
Pfizer
Phase 1 Withdrawn
NCT00729833 2014-06-09
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT00474760 2013-12-17
Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors
Pfizer
Phase 1 Completed
NCT00976508 2013-12-13
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT00927966 2013-11-14
RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms
Dana-Farber Cancer Institute
Phase 1 Completed
NCT01653158 2013-10-30
CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies
Pfizer
Phase 1 Completed
NCT00603538 2013-04-11
Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer
Pfizer
Phase 1 Completed
NCT00560573 2013-03-21
Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Pfizer
Phase 1 Completed
NCT01536145 2013-03-15
CP-751,871 Treatment For Patients With Multiple Myeloma
Pfizer
Phase 1 Completed